ClinicalTrials.Veeva

Menu

Differences in ECG- vs. proLonged cardIac MonItor-DeTected Atrial Fibrillation in STROKE Patients (DELIMIT AF-STROKE)

L

Lawson Health Research Institute

Status

Active, not recruiting

Conditions

TIA
Atrial Fibrillation
Stroke

Treatments

Diagnostic Test: Prolonged cardiac monitoring
Diagnostic Test: ECG

Study type

Observational

Funder types

Other

Identifiers

NCT05822791
ReDA ID 13446

Details and patient eligibility

About

The present study is an investigator-initiated, single-center, retrospective study based on data from the London Ontario Stroke Registry (LOSR), aiming to compare the characteristics and outcomes of ECG-detected and Device-Detected atrial fibrillation in patients with ischemic stroke and transient ischemic attack.

Full description

Patients with ischemic stroke and transient ischemic attack (TIA) without known atrial fibrillation (AF) are investigated with Prolonged Cardiac Monitoring (PCM) to detect AF. It is unclear if AF detected on 12-lead ECG after stroke occurrence bears the same risk of stroke as Device-detected AF. The investigators hypothesize, that Device-detected AF has a lower risk of ischemic stroke recurrence. The investigators will conduct a retrospective analysis of prospectively collected data from consecutive patients enrolled in the London Ontario Stroke Registry, (Ontario, Canada). The primary outcome will be a recurrent ischemic stroke at the end of the available follow-up window. The investigators will include ischemic stroke and TIA patients with ECG-detected AF and those with Device-detected AF on at least 7 days of Holter monitoring.

Enrollment

366 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥18 years
  • Patient with a diagnosis of ischemic stroke or TIA.
  • ECG-diagnosed AF or PCM-detected AF post ischemic stroke or TIA

Exclusion criteria

  • Individuals younger than18 years-old
  • Patients without IS or TIA diagnosis

Trial design

366 participants in 2 patient groups

ECG-Detected AF
Description:
Patients with atrial fibrillation detected on 12-lead ECGs done post-stroke
Treatment:
Diagnostic Test: ECG
Device-Detected AF
Description:
Patients with atrial fibrillation detected on prolonged Holter monitoring lasting at least 7 days.
Treatment:
Diagnostic Test: Prolonged cardiac monitoring

Trial contacts and locations

1

Loading...

Central trial contact

Jennifer Moussa; Diana Ayan, MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems